Clinical Trial Update: Safety, Efficacy Evaluation of Recombinant Coagulation Factor VIII Injection in Subjects With Hemophilia A. [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating safety and efficacy of recombinant coagulation factor VIII injection in subjects with Hemophilia A.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia

Drugs mentioned

• recombinant coagulation factor VIII injection (factor VIII recombinant)

Snippet

Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Conditions: Hemophilia A | Phase 3 | Status: UNKNOWN